Viewing Study NCT00622869


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-02-22 @ 7:03 PM
Study NCT ID: NCT00622869
Status: COMPLETED
Last Update Posted: 2013-05-27
First Post: 2008-02-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Sponsor: Novartis Pharmaceuticals
Organization: